Skip to content

SRPT SAREPTA THERAPEUTICS INC

Follow

COM (common), issuer CIK 873303

Filings received so far for Q3 2026: 9 13F filers report a position in SRPT shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
GAMMA Investing LLC2,191$39.9K<0.01%-50813F-HRTimeline
ATWOOD & PALMER INC1,400$25.5K<0.01%013F-HRTimeline
Farther Finance Advisors, LLC1,107$20.2K<0.01%-1,22113F-HRTimeline
Versant Capital Management, Inc478$8.71K<0.01%+2813F-HRTimeline
CoreCap Advisors, LLC292$5.32K<0.01%+28913F-HRTimeline
MassMutual Private Wealth & Trust, FSB129$2.35K<0.01%-413F-HRTimeline
MJT & Associates Financial Advisory Gro…69$1.26K<0.01%013F-HRTimeline
GILPIN WEALTH MANAGEMENT, LLC9$164<0.01%013F-HRTimeline
Davis Capital Management6$109<0.01%013F-HRTimeline